Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ki Back Chu

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Vaccines|August 28, 2021
Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 DomainsKi-Back Chu, Hae-Ji Kang, Keon-Woong Yoon, et al.
Tropical Medicine and Infectious Disease|November 10, 2022
Recombinant Vaccinia Virus Expressing <i>Plasmodium berghei</i> Apical Membrane Antigen 1 or Microneme Protein Enhances Protection against <i>P. berghei</i> Infection in MiceMin-Ju Kim, Ki-Back Chu, Su-Hwa Lee, et al.
Parasites, Hosts and Diseases|June 5, 2024
Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1Min-Ju Kim, Ki Back Chu, Keon-Woong Yoon, et al.
Parasite Immunology|October 15, 2020
Protective immunity induced by CpG ODN-adjuvanted virus-like particles containing Toxoplasma gondii proteinsHae-Ji Kang, Ki-Back Chu, Min-Ju Kim, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Ivermectin Identified Using a High-Throughput Screening System Exhibits Anti-<i>Clonorchis sinensis</i> Activity in RatsSoon-Ok Lee, Hyeryon Lee, Ki Back Chu, et al.
Pharmaceutics|October 22, 2020
Evaluation of CpG-ODN-Adjuvanted <i>Toxoplasma Gondii</i> Virus-Like Particle Vaccine upon One, Two, and Three ImmunizationsHae-Ji Kang, Ki-Back Chu, Min-Ju Kim, et al.
Parasite Immunology|April 7, 2020
Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T gondii infectionHae-Ji Kang, Ki-Back Chu, Su-Hwa Lee, et al.
ACS Infectious Diseases|November 28, 2023
Protective Humoral Immune Response Induced by Recombinant Virus-like Particle Vaccine Expressing <i>Leishmania donovani</i> Surface AntigenKeon-Woong Yoon, Ki Back Chu, Gi-Deok Eom, et al.
Nanomedicine (London, England)|September 25, 2024
Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in miceGi-Deok Eom, Ki Back Chu, Jie Mao, et al.
Acta Tropica|December 18, 2024
Protective humoral immunity induced by virus-like particles expressing Toxoplasma gondii CST1 or MIC8Jie Mao, Gi-Deok Eom, Keon-Woong Yoon, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Vaccines|August 28, 2021
Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 DomainsKi-Back Chu, Hae-Ji Kang, Keon-Woong Yoon, et al.
Tropical Medicine and Infectious Disease|November 10, 2022
Recombinant Vaccinia Virus Expressing <i>Plasmodium berghei</i> Apical Membrane Antigen 1 or Microneme Protein Enhances Protection against <i>P. berghei</i> Infection in MiceMin-Ju Kim, Ki-Back Chu, Su-Hwa Lee, et al.
Parasites, Hosts and Diseases|June 5, 2024
Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1Min-Ju Kim, Ki Back Chu, Keon-Woong Yoon, et al.
Parasite Immunology|October 15, 2020
Protective immunity induced by CpG ODN-adjuvanted virus-like particles containing Toxoplasma gondii proteinsHae-Ji Kang, Ki-Back Chu, Min-Ju Kim, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Ivermectin Identified Using a High-Throughput Screening System Exhibits Anti-<i>Clonorchis sinensis</i> Activity in RatsSoon-Ok Lee, Hyeryon Lee, Ki Back Chu, et al.
Pharmaceutics|October 22, 2020
Evaluation of CpG-ODN-Adjuvanted <i>Toxoplasma Gondii</i> Virus-Like Particle Vaccine upon One, Two, and Three ImmunizationsHae-Ji Kang, Ki-Back Chu, Min-Ju Kim, et al.
Parasite Immunology|April 7, 2020
Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T gondii infectionHae-Ji Kang, Ki-Back Chu, Su-Hwa Lee, et al.
ACS Infectious Diseases|November 28, 2023
Protective Humoral Immune Response Induced by Recombinant Virus-like Particle Vaccine Expressing <i>Leishmania donovani</i> Surface AntigenKeon-Woong Yoon, Ki Back Chu, Gi-Deok Eom, et al.
Nanomedicine (London, England)|September 25, 2024
Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in miceGi-Deok Eom, Ki Back Chu, Jie Mao, et al.
Acta Tropica|December 18, 2024
Protective humoral immunity induced by virus-like particles expressing Toxoplasma gondii CST1 or MIC8Jie Mao, Gi-Deok Eom, Keon-Woong Yoon, et al.
Pageof 9